94 related articles for article (PubMed ID: 16082380)
1. Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells.
Yamamoto M; Nishimoto N; Davydova J; Kishimoto T; Curiel DT
Cancer Gene Ther; 2006 Feb; 13(2):194-202. PubMed ID: 16082380
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.
Shimada K; Serada S; Fujimoto M; Nomura S; Nakatsuka R; Harada E; Iwahori K; Tachibana I; Takahashi T; Kumanogoh A; Kishimoto T; Naka T
Cancer Sci; 2013 Nov; 104(11):1483-91. PubMed ID: 23962256
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effect of SOCS-1 through the suppression of STAT3 and p38 MAPK activation in gastric cancer cells.
Souma Y; Nishida T; Serada S; Iwahori K; Takahashi T; Fujimoto M; Ripley B; Nakajima K; Miyazaki Y; Mori M; Doki Y; Sawa Y; Naka T
Int J Cancer; 2012 Sep; 131(6):1287-96. PubMed ID: 22095154
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
[TBL] [Abstract][Full Text] [Related]
5. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses.
Sakurai H; Tashiro K; Kawabata K; Yamaguchi T; Sakurai F; Nakagawa S; Mizuguchi H
J Immunol; 2008 Apr; 180(7):4931-8. PubMed ID: 18354218
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
Lin YC; Lin CK; Tsai YH; Weng HH; Li YC; You L; Chen JK; Jablons DM; Yang CT
Oncol Rep; 2010 Dec; 24(6):1605-12. PubMed ID: 21042758
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
10. Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.
Nagi P; Vickers SM; Davydova J; Adachi Y; Takayama K; Barker S; Krasnykh V; Curiel DT; Yamamoto M
J Gastrointest Surg; 2003; 7(3):364-71. PubMed ID: 12654561
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral Delivery of an Adenoviral Vector Carrying the
Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
[TBL] [Abstract][Full Text] [Related]
12. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas.
Yu JH; Kim KH; Kim H
Int J Biochem Cell Biol; 2008; 40(4):677-88. PubMed ID: 18035585
[TBL] [Abstract][Full Text] [Related]
13. Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors.
Bilbao R; Reay DP; Hughes T; Biermann V; Volpers C; Goldberg L; Bergelson J; Kochanek S; Clemens PR
Gene Ther; 2003 Oct; 10(21):1821-9. PubMed ID: 12960972
[TBL] [Abstract][Full Text] [Related]
14. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
[TBL] [Abstract][Full Text] [Related]
15. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
[TBL] [Abstract][Full Text] [Related]
16. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
17. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
Isomoto H; Mott JL; Kobayashi S; Werneburg NW; Bronk SF; Haan S; Gores GJ
Gastroenterology; 2007 Jan; 132(1):384-96. PubMed ID: 17241887
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
Lejeune D; Demoulin JB; Renauld JC
Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
[TBL] [Abstract][Full Text] [Related]
20. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
